Market icon
Vaccinations

$0.0 Vol.

$0.0 Liq.

Expires Jan 1, 2022

Will the FDA give emergency use authorization or otherwise approve Paxlovid before 2022?

Will the FDA give emergency use authorization or otherwise approve Paxlovid before 2022?

About

This market will resolve to “Yes” if, by December 31, 2021, 11:59:59 PM ET, Paxlovid (also known under PF-07321332), or any product containing PF-07321332 receives an Emergency Use Authorization (EUA) or full approval from the FDA for treating COVID-19. Otherwise, this market will resolve to “No.” If the resolution source isn’t updated by the resolution date, credible news reports may be used instead.

Learn more about Paxlovid: https://apnews.com/article/coronavirus-pandemic-science-business-health-medication-eeea3c6a5f6428479e35bc1bcd7aec52.
Market icon
Vaccinations

$0.0 Vol.

$0.0 Liq.

Expires Jan 1, 2022

Will the FDA give emergency use authorization or otherwise approve Paxlovid before 2022?

Will the FDA give emergency use authorization or otherwise approve Paxlovid before 2022?

About

This market will resolve to “Yes” if, by December 31, 2021, 11:59:59 PM ET, Paxlovid (also known under PF-07321332), or any product containing PF-07321332 receives an Emergency Use Authorization (EUA) or full approval from the FDA for treating COVID-19. Otherwise, this market will resolve to “No.” If the resolution source isn’t updated by the resolution date, credible news reports may be used instead.

Learn more about Paxlovid: https://apnews.com/article/coronavirus-pandemic-science-business-health-medication-eeea3c6a5f6428479e35bc1bcd7aec52.

Volume

$0

Liquidity

$0

End Date

Jan 1, 2022

Outcome: Yes

Will the FDA give emergency use authorization or otherwise approve Paxlovid before 2022?